Leadership & Management
Cardinal Health MD on leadership’s new currency in a ‘decade of disorientation’

As healthcare leaders confront a period of accelerating change, Neroli Manning, Managing Director of Cardinal Health ANZ, joins the Health Industry Hub senior leadership series to explore what leadership looks like when strategic clarity must be formed without the comfort of fixed contours.
In her first year at the helm of the ANZ business, Manning reflects on the consequential shifts reshaping the healthcare ecosystem, from the recalibration of stakeholder expectations to the redefinition of value across the care continuum. Framed by the work of University of Sydney leadership researchers Professors Sandra Peter and Kai Riemer, the conversation explores the concept of the ‘Grounded Leader’ navigating a ‘decade of disorientation’.
Within this context, the discussion turns to a defining structural shift in the system, the reconfiguration of trust. As confidence in institutions and leaders faces increasing scrutiny, Manning unpacks what trust looks like in modern healthcare, where credibility is no longer granted by position. She explores how Cardinal Health engages with patients, clinicians and government to challenge perceptions of value.
The conversation also examines the complex challenge of working across difference. As workplaces become more diverse in experience, expectations and perspectives, Manning explores the delicate balancing act of creating coherence without diminishing plurality.
In sharing advice for the next generation of senior leaders, Manning reflects on how to navigate an increasingly unpredictable landscape without being defined by its volatility, and the importance of remaining grounded in purpose even as the external environment continues to shift and reconfigure.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - Pharmaceuticals
Inside the tensions shaping PBAC decision
The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]
MoreNews - MedTech & Diagnostics
GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda
GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]
MoreNews - MedTech & Diagnostics
MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy
The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]
MoreNews - Pharmaceuticals
New breast cancer drug fills gap left by Zoladex market withdrawal
From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]
More